A Syntactico-Semantic Analysis of Ǧahd (=deny) Structure and its Equivalences in Quran’s Persian Translations
Jordan Journal of Modern Languages and Literature · 01.03.2026 · 23
DOI: 10.47012/jjmll.18.1.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jordan Journal of Modern Languages and Literature, online erschienen am 01.03.2026. Verfasst von Ali Hajikhani.
Abstract (Originalsprache)
The word Ǧahd and Ǧahd structures being complex and polyvalent in the Arabic language, it is challenging to find an appropriate equivalent for this structure in most languages. This article deals with the analysis of the structure of Ǧahd in 2 forms “Mā kāna al-fāilo liyaf’al” and “Mā kāna lilfāilo an yaf’al”, some of which have been criticized and evaluated after providing suitable equivalents for them in Persian. The most important results of this research indicate that in the analysis of the structure of Ǧahd, either the Astarābādi’s point of view according to which Kāna belongs to Munāsiban should be used, or Kāna defined as “sabata”[«ثَبَتَ»] should be taken into consideration. According to the first opinion, Ǧahd structure is translatable to: “It is not in the subject’s dignity to do so” and according to the second opinion, Ǧahd is articulated and interpreted as: “The subject is not such as to do so”.
Zitieren
APA
Hajikhani, A. (2026). A Syntactico-Semantic Analysis of Ǧahd (=deny) Structure and its Equivalences in Quran’s Persian Translations. Jordan Journal of Modern Languages and Literature, 23. https://doi.org/10.47012/jjmll.18.1.2
Vancouver
Hajikhani A. A Syntactico-Semantic Analysis of Ǧahd (=deny) Structure and its Equivalences in Quran’s Persian Translations. Jordan Journal of Modern Languages and Literature. 2026:23. doi:10.47012/jjmll.18.1.2
BibTeX
@article{Hajikhani2026,
author = {Hajikhani, Ali},
title = {A Syntactico-Semantic Analysis of Ǧahd (=deny) Structure and its Equivalences in Quran’s Persian Translations},
journal = {Jordan Journal of Modern Languages and Literature},
year = {2026},
pages = {23},
doi = {10.47012/jjmll.18.1.2}
}
EUVIMED